Skip to main content
Skip to main content
BNKK logo

Bonk, Inc. (BNKK) Stock Analysis

Educational signal · not a buy or sell recommendation · How to read this

$1.36 -$0.10 (-6.85%) |Weak · 17
Bonk, Inc. (BNKK) bottom line: signals are mixed — the Council read leans Split View (35/100) while the AI fundamental score is 17/100 (grade F); the two lenses disagree, so weigh the breakdown below. Strongest signal: Ken Griffin bullish · Biggest watch-out: Financial Safety weak.Educational signal, not a buy or sell recommendation. Compare sector peers → · Read the method →
MCap: $10.9M| Vol: 71.7K| 52-wk range: $0.907 – $16.87

Market cap $10.9M is the value of all shares combined. Beta 2.16: the stock has moved about 116% more than the S&P 500.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 10, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Bonk, Inc. (BNKK) trades at $1.36 with MoonshotScore 17/100 (Grade F). Market cap: $10.9M, Sector: Consumer defensive.

Price as of Sep 11, 2026 · Last analyzed: May 10, 2026
Bonk, Inc., operating as Safety Shot, Inc., focuses on over-the-counter and consumer products, including its flagship Safety Shot Beverage designed to lower blood alcohol content. The company also offers solutions for hair loss, vitiligo, eczema, and sexual wellness, distributing through direct sales, retailers, and e-commerce.

Analyst Coverage for BNKK: BNKK does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates BNKK against Consumer Defensive peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.

Watch the BNKK film Every key number, told as a short cinematic story — just press play. ~2 min

These figures come from statements filed 12 months ago — the most recent this company has published.

Council Score · Weighted Average of 3 Disciplines
Split View 35/100 · D

BNKK: 2/3 scored disciplines lean bearish. Dominant signal: Ken Griffin bullish.

How is this calculated? →
MoonshotScore · Five-pillar engine · 17/100
Business Quality
Negative Is this a genuinely good business?
Financial Safety
Negative Could this blow up on me?
Valuation
Negative Am I paying a fair price?
Growth Durability
Neutral Is the growth real and likely to last?
Momentum
Negative Is the market already moving on this?

Strongest side: Growth Durability (6/10, Neutral). Weakest side: Financial Safety (0/10, Negative).

Legends Council · 5 Legends + Moon AI

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated)Ray Dalio
Favorable read
Griffin-style lens (simulated)Ken Griffin
Favorable read
Simons-style lens (simulated)Jim Simons
Neutral read
Englander-style lens (simulated)Izzy Englander
Neutral read
Klarman-style lens (simulated)Seth Klarman
Unfavorable read
Moon AI lens (model)
Neutral read
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Weak
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →
The lenses are modelled on the published principles of the investors named. We are not affiliated with them, they have not endorsed this, and it is not their opinion of this stock.

Why this analysis is different

  • A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
  • An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
  • Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Bonk, Inc. (BNKK) Consumer Business Overview

CEOJarrett A. Boon
Employees8
HeadquartersJupiter, FL, US
IPO Year2020

Bonk, Inc. (BNKK), under the brand Safety Shot, develops and distributes consumer products, including its flagship beverage targeting blood alcohol reduction. With a small team and a focus on e-commerce and retail channels, the company operates in the competitive non-alcoholic beverage sector, facing challenges in profitability and market penetration.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: May 10, 2026

What Is the Investment Thesis for BNKK?

AI-written as of May 10, 2026 — figures and tone reflect the data available then, not today's score.

Investing in Bonk, Inc. (BNKK) presents a high-risk, high-reward scenario. The company's focus on the Safety Shot Beverage, targeting blood alcohol reduction, could tap into a niche market. However, the company's negative profit margin of -1735.2% raises concerns about its financial sustainability. Key to the investment thesis is the successful market penetration of Safety Shot and the ability to scale production and distribution efficiently. The company's gross margin of 31.5% indicates potential profitability if sales volumes increase significantly. The high beta of 2.16 suggests significant volatility, reflecting the speculative nature of the stock. Growth catalysts include securing major retail partnerships and expanding the e-commerce presence. Investors should closely monitor sales figures, marketing effectiveness, and the company's ability to manage costs and achieve profitability.

Based on FMP financials and quantitative analysis

BNKK Key Highlights

AI-written as of May 10, 2026 — figures and tone reflect the data available then, not today's score.

Market capitalization of $10.9M indicates a micro-cap stock with high growth potential but also significant risk.

  • Negative profit margin of -1735.2% highlights the company's current lack of profitability and the need for significant operational improvements.
  • Gross margin of 31.5% suggests potential for profitability if the company can increase sales volume and reduce operating expenses.
  • Beta of 2.16 indicates high volatility, reflecting the speculative nature of the stock and its sensitivity to market fluctuations.
  • No dividend yield reflects the company's focus on reinvesting earnings for growth rather than returning capital to shareholders.

Who Are BNKK's Competitors?

BNKK is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
BRFH Barfresh Food Group, Inc. $1.23 -2.78% $19.8M
ZVIA Zevia PBC $1.25 +1.21% $90.1M 345-pillar
BUDA Buda Juice Inc. $7.99 0.00% $100M 745-pillar
OTLY Oatly Group AB $12.53 -0.63% $391M
FIZZ National Beverage Corp. $30.91 +1.21% $2.89B 845-pillar
COCO The Vita Coco Company, Inc. $51.85 +1.47% $2.98B 885-pillar
CELH Celsius Holdings, Inc. $27.51 +3.30% $7.03B 635-pillar
PRMB Primo Brands Corporation $20.56 -1.39% $7.46B 525-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are BNKK's Key Strengths?

Unique product offering with Safety Shot Beverage.

  • Diverse product portfolio in health and wellness.
  • Multiple distribution channels.
  • Focus on over-the-counter solutions.

What Are BNKK's Weaknesses?

Negative profit margin.

  • Small employee base.
  • Limited brand awareness.
  • High beta indicating volatility.

What Could Drive BNKK Stock Higher?

Securing partnerships with major retail chains to expand distribution of Safety Shot Beverage.

  • Expansion of e-commerce platform and online marketing efforts to drive direct-to-consumer sales.
  • Launch of new health and wellness beverage products to diversify revenue streams.

What Are the Key Risks for BNKK?

Financial-distress signal — its Altman Z-Score of -14.90 sits in the distress zone (elevated bankruptcy risk).

  • Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
  • High competition from established beverage companies and other health-focused brands.
  • Regulatory changes affecting the over-the-counter beverage and health product markets.
  • Negative profit margin and the need for significant operational improvements to achieve profitability.
  • Product liability claims related to the Safety Shot Beverage or other health and wellness products.

What Are the Growth Opportunities for BNKK?

  • Expansion of Retail Partnerships: Securing partnerships with major retail chains and convenience stores represents a significant growth opportunity for Bonk, Inc. Increased retail presence would enhance product visibility and accessibility to a broader customer base. The timeline for achieving this growth opportunity is within the next 12-24 months, contingent on successful negotiations and distribution agreements. The market size for retail sales of non-alcoholic beverages is substantial, offering significant revenue potential if Safety Shot can gain traction on store shelves.
  • E-commerce Channel Development: Enhancing the company's e-commerce platform and online marketing efforts can drive direct-to-consumer sales and expand its reach beyond traditional retail channels. Investing in targeted online advertising and social media campaigns can increase brand awareness and customer engagement. The e-commerce market for health and wellness products is growing rapidly, providing a favorable environment for Bonk, Inc. to capture online sales. This growth opportunity can be realized within the next 6-12 months with focused investment and strategic marketing initiatives.
  • Product Line Extension: Expanding the product line beyond Safety Shot to include other health and wellness beverages can diversify revenue streams and attract a wider range of customers. Developing new formulations targeting specific health needs or consumer preferences can create additional market opportunities. The timeline for product line expansion is within the next 18-36 months, requiring research and development efforts and market testing. The market for functional beverages is expanding, offering potential for Bonk, Inc. to capitalize on emerging trends.
  • International Market Expansion: Exploring opportunities to expand into international markets can unlock new growth potential and diversify the company's revenue base. Identifying countries with favorable regulatory environments and consumer demand for health and wellness products is crucial for successful international expansion. The timeline for international expansion is within the next 24-48 months, requiring market research, regulatory compliance, and distribution partnerships. The global market for non-alcoholic beverages is vast, offering significant long-term growth opportunities.
  • Strategic Acquisitions or Partnerships: Pursuing strategic acquisitions or partnerships with complementary businesses can accelerate growth and expand the company's capabilities. Acquiring companies with established distribution networks or complementary product lines can create synergies and enhance market position. The timeline for strategic acquisitions or partnerships is variable, depending on market conditions and available opportunities. The potential impact on growth is significant, with the ability to accelerate market penetration and expand product offerings.

What Are BNKK's Competitive Advantages?

  • Proprietary formulation of Safety Shot Beverage.
  • Brand recognition in the niche market of blood alcohol reduction products.
  • Established distribution network through direct sales, distributors, retailers, and e-commerce.

What Does BNKK Do?

Bonk, Inc., now known as Safety Shot, Inc., was founded in 2018 and is headquartered in Jupiter, Florida. The company's primary offering is the Safety Shot Beverage, an over-the-counter drink formulated to lower blood alcohol content. In addition to Safety Shot, the company provides a range of consumer products, including treatments for hair loss, vitiligo, eczema, and products aimed at enhancing sexual wellness. These products are distributed through various channels, including direct sales to customers, partnerships with distributors and retailers, and via e-commerce platforms. The rebranding to Safety Shot, Inc. in September 2023 reflects the company's strategic focus on its flagship beverage product. Bonk, Inc. aims to capture a segment of the market focused on health and wellness solutions, particularly targeting consumers seeking products that address specific health concerns and lifestyle enhancements. The company's ability to effectively market and distribute its products, especially Safety Shot, will be critical to its long-term success in the competitive consumer products landscape. With a small team of 8 employees, Bonk, Inc. faces the challenge of scaling its operations and expanding its market reach while maintaining product quality and customer satisfaction.

What Products and Services Does BNKK Offer?

  • Develops and markets the Safety Shot Beverage, an over-the-counter drink designed to lower blood alcohol content.
  • Offers hair loss treatment products.
  • Provides solutions for vitiligo.
  • Manufactures eczema cream.
  • Sells sexual wellness products.
  • Distributes products through direct sales, distributors, retailers, and e-commerce websites.

How Does BNKK Make Money?

  • Develops and manufactures over-the-counter health and wellness products.
  • Sells products directly to consumers through its website and other online platforms.
  • Partners with distributors and retailers to expand market reach.
  • Generates revenue through product sales.

What Industry Does BNKK Operate In?

Bonk, Inc. operates within the competitive non-alcoholic beverage sector, which is characterized by evolving consumer preferences and a focus on health and wellness. The market includes established players and emerging brands vying for market share through product innovation and effective marketing. Bonk, Inc.'s Safety Shot Beverage aims to carve out a niche by targeting consumers seeking to lower blood alcohol content. The company faces competition from traditional beverage companies and other health-focused brands. Success depends on effective branding, distribution, and demonstrating the efficacy of its products.

Who Are BNKK's Key Customers?

  • Individuals seeking to lower their blood alcohol content.
  • Consumers looking for hair loss treatments.
  • Individuals seeking solutions for vitiligo and eczema.
  • Customers interested in sexual wellness products.
Model self-rating on this text: 64% (not a measure of the evidence) Updated: May 10, 2026

Research confidence

Medium 60/100

Enough evidence to be useful, with gaps worth knowing about.

  • Scored on 91% of our measures
  • Price is current
  • No filing on record
  • No analyst coverage

Why 17?

Measured against companies in the same sector. The figures below are the factor contributions the scoring engine itself produced.

What is helping

  • +0.54 Price to book (Valuation)
  • +0.48 Revenue growth (Growth)
  • +0.25 3-year revenue per share (Growth)

What is holding it back

  • -0.78 Return on invested capital (Business Quality)
  • -0.78 Return on equity (Business Quality)
  • -0.78 Return on assets (Business Quality)

Risk penalties applied

  • -1.89 Bankruptcy-risk score in the distress zone
  • -2.00 Loss-making with negative retained earnings

Contribution = how far the company sits from its sector on that measure, weighted by how much the pillar counts. Not investment advice. How the score is built →

MoonshotScore History

Recorded daily since 2026-08-23 · 19 snapshots

2026-08-23 15
2026-08-26 15
2026-08-29 15
2026-09-01 16
2026-09-04 17
2026-09-07 17
2026-09-10 17

What changed?

The grade moved from 15 to 17 (+2).

What moved it up or down:

  • +10 Momentum
  • +6 Valuation
  • +2 Growth Durability

Held back by:

  • -1 Financial Safety

Over the same 18 days the stock moved +24.8%.

Company Profile

Bonk, Inc. operates in the Beverages - Non-Alcoholic industry within the Consumer Defensive sector. It is headquartered in Scottsdale, US. The company is led by CEO Jarrett A. Boon. BNKK has traded publicly since 2020.

Bonk, Inc. Financial Trajectory

Bonk, Inc. (BNKK) reported $1.2M in revenue for Jun 2026, a decline of 73.2% compared to the prior quarter. The company recorded a net loss of $6.1M, with diluted EPS of $-1.41. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Consumer Defensive. Across the four most recent quarters, BNKK averaged $-4.90 in diluted EPS.

How Bonk, Inc. Is Valued

Bonk, Inc. carries a market capitalization of $10.9M, placing it in the micro-cap category. Relative to its peer group, BNKK's quantitative score of 17/100 is below the peer average of 66/100.

F-Score 2/9

Financial Health

Bonk, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -14.90 places it in the distress zone, a signal of elevated financial risk.

Net buying

Insider Activity

Over the past six months, Bonk, Inc. insiders filed 9 SEC Form 4 transactions — 0 sales and 9 purchases. On net that is roughly 75K shares acquired (about $148K) — insiders putting money in tends to read as conviction.

BNKK Financials

Fundamental Snapshot

Revenue Growth (FY)
+459.8%
Net Income Growth (FY)
-38.0%
EPS Growth (FY)
+50.1%
Free Cash Flow Growth (FY)
-36.2%
Return on Equity (TTM)
-155.0%
Current Ratio
1.3

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Unique product offering with Safety Shot Beverage.
  • Diverse product portfolio in health and wellness.
  • Multiple distribution channels.
  • Focus on over-the-counter solutions.

Bear Case

  • Negative profit margin.
  • Small employee base.
  • Limited brand awareness.
  • High beta indicating volatility.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · September 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Jun 2026 $1M -$6M -$1.41
Mar 2026 $4M -$2M -$0.43
Dec 2025 $2M -$43M -$9.93
Sep 2025 $2M -$34M -$7.82

Based on FMP financials and quantitative analysis

BNKK Latest News

BNKK Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for BNKK.

Price Targets

Wall Street price target analysis for BNKK.

BNKK MoonshotScore

17/100

What does this score mean?

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. BNKK scores 17/100 (Grade F): the number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.

Leadership: Jarrett A. Boon

CEO

Jarrett A. Boon serves as the CEO of Bonk, Inc. (Safety Shot, Inc.). As CEO, he is responsible for leading the company's strategic direction, overseeing operations, and driving growth initiatives. His leadership is crucial for the company's success in the competitive consumer products market.

Track Record: With limited data available, it's challenging to assess Jarrett A. Boon's specific track record at Bonk, Inc. However, his role in rebranding the company to Safety Shot, Inc. in September 2023 indicates a strategic focus on the flagship beverage product. His ability to navigate the company towards profitability and market expansion will be key indicators of his success.

BNKK Consumer Defensive Stock FAQ

What does the AI Score mean for BNKK?

BNKK holds an AI Score of 17/100 (Grade: F). This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.

Is BNKK a good stock?

Stock Expert AI does not rate BNKK buy, sell or hold. Bonk, Inc. carries a MoonshotScore of 17/100 on the five-pillar engine, a research rating against its peers. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.

What do analysts say about BNKK stock?

There is no analyst coverage information provided for Bonk, Inc. (BNKK). Due to the limited market capitalization and financial performance, it is possible that the company does not have significant analyst coverage.

What are the key factors to evaluate for BNKK?

Bonk, Inc. (BNKK) holds a MoonshotScore of 17/100 (low). Investing in Bonk, Inc. (BNKK) presents a high-risk, high-reward scenario. Not financial advice.

How frequently does BNKK data refresh on this page?

BNKK's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 calculations are scheduled daily at 10:15 UTC; the score's own date shows its last successful run.

What has driven BNKK's recent stock price performance?

Bonk, Inc. (BNKK) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Unique product offering with Safety Shot Beverage. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider BNKK overvalued or undervalued right now?

Bonk, Inc. (BNKK) is loss-making, so its trailing P/E is negative (-0.29x) and not usable for valuation — lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of BNKK?

Yes, most major brokerages offer fractional shares of Bonk, Inc. (BNKK) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track BNKK's earnings and financial reports?

Bonk, Inc. (BNKK) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for BNKK earnings announcements.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated MoonshotScore as of
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Limited financial data available.
  • Lack of analyst coverage information.
  • Small market capitalization and high volatility.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

More Stocks We Cover